Consort Medical, Aesica CDMO Services, announces key facility updates for manufacturing and packaging solutions at both its Pianezza and Monheim sites.
The redesigned oral liquids facility, at Pianezza, features the latest Marchesini equipment and will double the production capacity of oral formulated drugs to 28 million bottles per year. Qualification and validation activities will be taking place during Q4 2018 and, following receipt of the necessary local authorizations, the facility will be ready to start production in Q1 2019.
Responding to customer demand, the facility has been further equipped with new dissolution equipment to allow the production of a wider variety of oral solutions, including emulsions. The line is fully serialization ready and equipped with an innovative process monitoring system to support enhanced efficiency and quality.
The new double row blister and carton packaging line in Monheim has been designed by Uhlmann. This enhanced capability will come online in Q1 2019, following qualification, validation and receipt of regulatory approvals. The blister line will consist of a fully automated serialization station as well as an online integrated case packer. Due to its smart design and use of the latest technology, and enables rapid autonomous tool changing at the machine.
The machine has a capacity of up to 500 blisters and 300 boxes per minute and can blister all common materials, i.e. alumina, PVC and PP. Blister filling is checked by an optical camera system and can be printed online with art work.
“Ensuring high standards of quality and efficiency are key elements in our delivery of Industry 4.0,” said Manja Boerman, President Aesica CDMO Services, Consort Medical. “Our serialization technology is delivering full GMP-compliance for the European market, addressing anti-counterfeiting and fraud. Equipping our production lines with fully integrated serialization solutions and the latest process monitoring technologies are crucial.”